Sullivan, Lucas B.
Gui, Dan Y.
Heiden, Matthew G. Vander
Article History
First Online: 23 September 2016
Competing interests
: M.G.V.H. is a consultant and Scientific Advisory Board (SAB) member for Agios Pharmaceuticals, which seeks to target metabolism for cancer therapy, and is also an SAB member for Aeglea Biotherapeutics.